ETTXEntasis Therapeutics Holdin...


$ 2.19 $ -0.01 (-0.45 %)    

Friday, 08-Jul-2022 15:58:11 EDT
QQQ $ 482.88 $ 2.24 (0.47 %)
DIA $ 408.91 $ 0.43 (0.11 %)
SPY $ 560.81 $ 1.92 (0.34 %)
TLT $ 98.72 $ 0.06 (0.06 %)
GLD $ 232.16 $ -0.31 (-0.13 %)
$ 2.19
$ 2.18 x 600
$ 2.21 x 600
-- - --
$ 1.40 - $ 3.88
68,834
na
104.8M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 over-42-million-bet-on-this-biotechnology-stock-4-penny-stocks-insiders-are-buying

US producer prices are likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, foc...

 entasis-therapeutics-highlights-presentation-of-data-on-sulbactam-durlobactam-and-etx0462-at-2022-asm-microbe-annual-conference

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and ...

 58-biggest-movers-from-yesterday
58 Biggest Movers From Yesterday
05/24/2022 09:29:12

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its co...

 benzingas-top-ratings-upgrades-downgrades-for-may-6-2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-...

 10-biggest-price-target-changes-for-friday

Keybanc cut HubSpot, Inc. (NYSE: HUBS) price target from $535 to $461. HubSpot shares fell 0.4% to $340.00 in pre-market tr...

 cantor-fitzgerald-downgrades-entasis-therapeutics-hldg-to-neutral-lowers-price-target-to-2

Cantor Fitzgerald analyst Louise Chen downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Overweight to Neutral and lowe...

 entasis-therapeutics-hldg-q1-earnings-insights

  Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here'...

 entasis-therapeutics-hldg-q1-eps-032-down-from-029-yoy

Entasis Therapeutics Hldg (NASDAQ:ETTX) reported quarterly losses of $(0.32) per share. This is a 10.34 percent decrease over l...

 entasis-therapeutics-highlights-presentation-of-efficacy-safety-data-from-its-phase-3-attack-trial-at-european-congress-of-clinical-microbiology-and-infectious-diseases-conference

Presentations Highlight Topline Results, Sub-Analysis for sulbactam-durlobactam (SUL-DUR) WALTHAM, Mass., April 26, 2022 (GLOB...

 benzingas-top-ratings-upgrades-downgrades-for-march-16-2022

Upgrades

 alliance-global-partners-downgrades-entasis-therapeutics-hldg-to-neutral

Alliance Global Partners analyst James Molloy downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Buy to Neutral.

Core News & Articles

-SEC Filing

 benzingas-top-ratings-upgrades-downgrades-for-march-8-2022

Upgrades

 wedbush-downgrades-entasis-therapeutics-hldg-to-neutral-lowers-price-target-to-18

Wedbush analyst Robert Driscoll downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Outperform to Neutral and lowers the...

 benzingas-top-ratings-upgrades-downgrades-for-march-4-2022

Upgrades

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION